| Trial ID: | L2279 |
| Source ID: | NCT00413465
|
| Associated Drug: |
Escherichia Coli Endotoxin
|
| Title: |
Study of Renal Blood Flow During Human Endotoxemia
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Healthy|Type 2 Diabetes|Endotoxemia
|
| Interventions: |
DRUG: Escherichia Coli Endotoxin
|
| Outcome Measures: |
Primary: Renal plasma flow, Glomerular filtration rate, Plasma cytokine content, Endotoxemia score, Plasma angiotensin II and renin content, Plasma thromboxane B2 content, Plasma PAI-1 content | Secondary: Mean arterial pressure, Heart rate, Oxygen saturation, Body temperature,
|
| Sponsor/Collaborators: |
Sponsor: Rigshospitalet, Denmark
|
| Gender: |
MALE
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
32
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION
|
| Start Date: |
2006-11
|
| Completion Date: |
2007-12
|
| Results First Posted: |
|
| Last Update Posted: |
2006-12-19
|
| Locations: |
Intensiv Care Unit, Rigshospitalet,, Copenhagen, 2100, Denmark
|
| URL: |
https://clinicaltrials.gov/show/NCT00413465
|
